Jinwon Life Sciences VGXI New Factory Selected as ENR's '2023 Best Manufacturing Project' in the US

Jinwon Life Sciences announced on the 26th that the new factory located in Deison Technology Park, Conroe City, Texas, which serves as the headquarters and state-of-the-art production facility of VGXI, a plasmid DNA contract development and manufacturing organization (CDMO) subsidiary in the United States, has been selected as the '2023 Best Project in Manufacturing' by the Texas & Louisiana edition of the prestigious American construction engineering magazine ENR (Engineering News Record).

ENR, a globally influential construction magazine in the United States, ranks construction companies annually based on their business performance. It is recognized as a useful indicator for assessing the status of construction companies in the global construction market.

The ENR Texas & Louisiana edition forms an independent panel of industry experts each year to rigorously evaluate factors such as safety, innovation, technical quality, and contributions to the region or industry, selecting and announcing the best projects in each category. This year, the ENR Texas and Louisiana Best Project program comprehensively reviewed over 100 submitted projects and selected 17 best projects across categories and 11 recipients of merit awards.

Park Young-geun, CEO of Jinwon Life Sciences, said, “Despite difficult circumstances such as COVID-19, heavy rains in the Texas region, and the sharp rise in raw material prices due to the Ukraine-Russia war, the construction of the world's largest plasmid DNA production plant using the latest construction methods was made possible by the dedicated efforts of VGXI and the construction company BE&K.”

This content was produced with the assistance of AI translation services.